ACI SANT'ANTONIO, Italy, May 31, 2024 /PRNewswire/ SIFI announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive
SIFI receives positive CHMP opinion for AKANTIOR® (polihexanide 0 08%) in acanthamoeba keratitis lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Type B meeting feedback confirms SIFI's view that no additional data will be required for potential FDA approval of AKANTIORAKANTIOR is poised to become the first FDA-approved medication for
/PRNewswire/ SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug.
This follows the previously granted ODD for polihexanide in Acanthamoeba Keratitis by the FDA and EMA. An estimated 15,660 patients with fungal keratitis are diagnosed annually in the